{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:42:20Z","timestamp":1793407340044,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02115-8","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:57:05Z","timestamp":1764593825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuhui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangfeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shousen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"5","key":"2115_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: A review. JAMA. 2017;317(5):516\u201324. https:\/\/doi.org\/10.1001\/jama.2016.19699.","journal-title":"JAMA"},{"key":"2115_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf091","author":"A Fountas","year":"2025","unstructured":"Fountas A, Lithgow K, Loughrey PB, et al. Conservatively managed non-functioning pituitary macroadenomas - cohort study from the UK Non-functioning pituitary adenoma consortium. Eur J Endocrinol. 2025. https:\/\/doi.org\/10.1093\/ejendo\/lvaf091.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2115_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","volume":"19","author":"K Ho","year":"2023","unstructured":"Ho K, Kaiser UB, Chanson P, et al. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat Rev Endocrinol. 2023;19(11):671\u20138. https:\/\/doi.org\/10.1038\/s41574-023-00883-8.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2115_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017;28(3):228\u201343. https:\/\/doi.org\/10.1007\/s12022-017-9498-z.","journal-title":"Endocr Pathol"},{"issue":"1","key":"2115_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. 2022;33(1):6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7.","journal-title":"Endocr Pathol"},{"key":"2115_CR6","doi-asserted-by":"publisher","unstructured":"Jiang S, Chen X, Wu Y, Wang R, Bao X. An update on silent corticotroph adenomas: diagnosis, mechanisms, clinical features, and management. Cancers (Basel). 2021;13(23). https:\/\/doi.org\/10.3390\/cancers13236134.","DOI":"10.3390\/cancers13236134"},{"issue":"4","key":"2115_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"M Lopes","year":"2017","unstructured":"Lopes M. The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017;134(4):521\u201335. https:\/\/doi.org\/10.1007\/s00401-017-1769-8.","journal-title":"Acta Neuropathol"},{"key":"2115_CR8","doi-asserted-by":"publisher","first-page":"870172","DOI":"10.3389\/fendo.2022.870172","volume":"13","author":"G Demarchi","year":"2022","unstructured":"Demarchi G, Perrone S, Esper RG, et al. Case report: progression of a silent corticotroph tumor to an aggressive secreting corticotroph tumor, treated by Temozolomide. Changes in the Clinic, the Pathology, and the \u03b2-Catenin and \u03b1-SMA expression. Front Endocrinol (Lausanne). 2022;13:870172. https:\/\/doi.org\/10.3389\/fendo.2022.870172.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2115_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/cen.12443","volume":"81","author":"L Cazabat","year":"2014","unstructured":"Cazabat L, Dupuy M, Boulin A, et al. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol (Oxf). 2014;81(4):566\u201372. https:\/\/doi.org\/10.1111\/cen.12443.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2115_CR10","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888\u2013921. https:\/\/doi.org\/10.1210\/jc.2016-2118.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2115_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3803\/EnM.2023.1838","volume":"38","author":"E Whyte","year":"2023","unstructured":"Whyte E, Nezu M, Chik C, et al. Update on current evidence for the diagnosis and management of nonfunctioning pituitary neuroendocrine tumors. Endocrinol Metab (Seoul). 2023;38(6):631\u201354. https:\/\/doi.org\/10.3803\/EnM.2023.1838.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"2115_CR12","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, et al. Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab. 2019;104(7):2473\u201389. https:\/\/doi.org\/10.1210\/jc.2018-00688.","journal-title":"J Clin Endocrinol Metab"},{"key":"2115_CR13","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/j.wneu.2018.04.070","volume":"115","author":"D Kim","year":"2018","unstructured":"Kim D, Ku CR, Park SH, et al. Clinical parameters to distinguish silent corticotroph adenomas from other nonfunctioning pituitary adenomas. World Neurosurg. 2018;115:e464\u201371. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.070.","journal-title":"World Neurosurg"},{"issue":"8","key":"2115_CR14","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1210\/jc.2003-031531","volume":"89","author":"HL Storr","year":"2004","unstructured":"Storr HL, Isidori AM, Monson JP, et al. Prepubertal cushing\u2019s disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab. 2004;89(8):3818\u201320. https:\/\/doi.org\/10.1210\/jc.2003-031531.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2115_CR15","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG, et al. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg. 2021;135(6):1706\u201313. https:\/\/doi.org\/10.3171\/2020.10.JNS203236.","journal-title":"J Neurosurg"},{"issue":"1","key":"2115_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11102-017-0844-4","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim D, Yedinak CG, et al. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary. 2018;21(1):32\u201340. https:\/\/doi.org\/10.1007\/s11102-017-0844-4.","journal-title":"Pituitary"},{"key":"2115_CR17","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/j.wneu.2022.01.119","volume":"161","author":"L Huang","year":"2022","unstructured":"Huang L, Fatterpekar G, Charles S, et al. Clinical course and unique features of silent corticotroph adenomas. World Neurosurg. 2022;161:e274\u201381. https:\/\/doi.org\/10.1016\/j.wneu.2022.01.119.","journal-title":"World Neurosurg"},{"key":"2115_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.wneu.2017.03.109","volume":"103","author":"J Zhang","year":"2017","unstructured":"Zhang J, Gu J, Ma Y, et al. Uneven distribution of regional blood supply prompts the cystic change of pituitary adenoma. World Neurosurg. 2017;103:37\u201344. https:\/\/doi.org\/10.1016\/j.wneu.2017.03.109.","journal-title":"World Neurosurg"},{"key":"2115_CR19","doi-asserted-by":"publisher","first-page":"111364","DOI":"10.1016\/j.mehy.2024.111364","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xian L, Chen L, Li J, Wang S. A novel hypothesis on cystic changes in pituitary adenomas and their association with a distinct local blood supply pattern. Med Hypotheses. 2024;187:111364. https:\/\/doi.org\/10.1016\/j.mehy.2024.111364.","journal-title":"Med Hypotheses"},{"issue":"987","key":"2115_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1259\/bjr\/76663418","volume":"83","author":"BT Yang","year":"2010","unstructured":"Yang BT, Chong VF, Wang ZC, Xian JF, Chen QH. Sphenoid sinus ectopic pituitary adenomas: CT and MRI findings. Br J Radiol. 2010;83(987):218\u201324. https:\/\/doi.org\/10.1259\/bjr\/76663418.","journal-title":"Br J Radiol"},{"issue":"3","key":"2115_CR21","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00330-021-08361-3","volume":"32","author":"W Rui","year":"2022","unstructured":"Rui W, Qiao N, Wu Y, et al. Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas. Eur Radiol. 2022;32(3):1570\u20138. https:\/\/doi.org\/10.1007\/s00330-021-08361-3.","journal-title":"Eur Radiol"},{"issue":"9","key":"2115_CR22","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s40618-023-02042-2","volume":"46","author":"H Wang","year":"2023","unstructured":"Wang H, Chang J, Zhang W, et al. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas. J Endocrinol Invest. 2023;46(9):1843\u201354. https:\/\/doi.org\/10.1007\/s40618-023-02042-2.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2115_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11102-021-01133-8","volume":"24","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhu J, Feng M, et al. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary. 2021;24(4):564\u201373. https:\/\/doi.org\/10.1007\/s11102-021-01133-8.","journal-title":"Pituitary"},{"issue":"11","key":"2115_CR24","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00701-021-04911-2","volume":"163","author":"A Goyal-Honavar","year":"2021","unstructured":"Goyal-Honavar A, Sarkar S, Asha HS, et al. A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors. Acta Neurochir (Wien). 2021;163(11):3143\u201354. https:\/\/doi.org\/10.1007\/s00701-021-04911-2.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"2115_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s11102-024-01428-6","volume":"27","author":"N Sahakian","year":"2024","unstructured":"Sahakian N, Goetz L, Appay R, et al. Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent. Pituitary. 2024;27(5):644\u201353. https:\/\/doi.org\/10.1007\/s11102-024-01428-6.","journal-title":"Pituitary"},{"issue":"3","key":"2115_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S2213-8587(23)00382-0","volume":"12","author":"K Ho","year":"2024","unstructured":"Ho K, Fleseriu M, Wass J, et al. A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol. 2024;12(3):209\u201314. https:\/\/doi.org\/10.1016\/S2213-8587(23)00382-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2115_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11102-023-01335-2","volume":"26","author":"KY Fong","year":"2023","unstructured":"Fong KY, Lim M, Fu S, et al. Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis. Pituitary. 2023;26(4):461\u201373. https:\/\/doi.org\/10.1007\/s11102-023-01335-2.","journal-title":"Pituitary"},{"key":"2115_CR28","doi-asserted-by":"publisher","first-page":"109023","DOI":"10.1016\/j.clineuro.2025.109023","volume":"256","author":"A Goyal-Honavar","year":"2025","unstructured":"Goyal-Honavar A, Konar S, Phaneendra GS, et al. Early adjuvant radiation reduces the rate of recurrence following surgery for silent corticotroph pituitary neuroendocrine tumors. Clin Neurol Neurosurg. 2025;256:109023. https:\/\/doi.org\/10.1016\/j.clineuro.2025.109023.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"2115_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/2017.5.JNS163069","volume":"129","author":"IJ Pomeraniec","year":"2018","unstructured":"Pomeraniec IJ, Kano H, Xu Z, et al. Early versus late gamma knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study. J Neurosurg. 2018;129(3):648\u201357. https:\/\/doi.org\/10.3171\/2017.5.JNS163069.","journal-title":"J Neurosurg"},{"key":"2115_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02674-6","author":"B Biagetti","year":"2025","unstructured":"Biagetti B, Cardona-Arias A, Torre EM, et al. Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study. J Endocrinol Invest. 2025. https:\/\/doi.org\/10.1007\/s40618-025-02674-6.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2115_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13014-022-02133-z","volume":"17","author":"T Charleux","year":"2022","unstructured":"Charleux T, Vendrely V, Huchet A, et al. Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery? Radiat Oncol. 2022;17(1):165. https:\/\/doi.org\/10.1186\/s13014-022-02133-z.","journal-title":"Radiat Oncol"},{"key":"2115_CR32","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/j.wneu.2023.09.067","volume":"180","author":"AV Sathe","year":"2023","unstructured":"Sathe AV, Siu A, Kang KC, et al. Early versus delayed fractionated stereotactic radiotherapy for nonfunctioning pituitary adenoma. World Neurosurg. 2023;180:e317\u201323. https:\/\/doi.org\/10.1016\/j.wneu.2023.09.067.","journal-title":"World Neurosurg"},{"issue":"3","key":"2115_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1227\/neu.0000000000003142","volume":"96","author":"W He","year":"2025","unstructured":"He W, Yao S, Yu Y, et al. Treatment strategies and Long-Term outcomes in silent corticotroph adenomas: A Single-Center retrospective study of 367 cases. Neurosurgery. 2025;96(3):611\u201321. https:\/\/doi.org\/10.1227\/neu.0000000000003142.","journal-title":"Neurosurgery"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02115-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:49:31Z","timestamp":1767707371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-025-02115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2115"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02115-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Fuzong Clinical Medical College of Fujian Medical University (Approval No. 2024-011). Given the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee in accordance with relevant laws and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}